These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26016732)

  • 21. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liraglutide Inhibits Osteoclastogenesis and Improves Bone Loss by Downregulating Trem2 in Female Type 1 Diabetic Mice: Findings From Transcriptomics.
    Yu J; Shi YC; Ping F; Li W; Zhang HB; He SL; Zhao Y; Xu LL; Li YX
    Front Endocrinol (Lausanne); 2021; 12():763646. PubMed ID: 34975749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease.
    Holscher C
    Recent Pat CNS Drug Discov; 2010 Jun; 5(2):109-17. PubMed ID: 20337586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis.
    Tashiro Y; Sato K; Watanabe T; Nohtomi K; Terasaki M; Nagashima M; Hirano T
    Peptides; 2014 Apr; 54():19-26. PubMed ID: 24418070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.
    Mieczkowska A; Mansur S; Bouvard B; Flatt PR; Thorens B; Irwin N; Chappard D; Mabilleau G
    Osteoporos Int; 2015 Jan; 26(1):209-18. PubMed ID: 25127672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon-like peptide-1 and vitamin D: anti-inflammatory response in diabetic kidney disease in db/db mice and in cultured endothelial cells.
    Einbinder Y; Ohana M; Benchetrit S; Zehavi T; Nacasch N; Bernheim J; Zitman-Gal T
    Diabetes Metab Res Rev; 2016 Nov; 32(8):805-815. PubMed ID: 26991522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice.
    Porter D; Faivre E; Flatt PR; Hölscher C; Gault VA
    Peptides; 2012 May; 35(1):1-8. PubMed ID: 22465882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
    Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption.
    Mabilleau G; Perrot R; Mieczkowska A; Boni S; Flatt PR; Irwin N; Chappard D
    Bone; 2016 Oct; 91():102-12. PubMed ID: 27451082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Nagashima M; Watanabe T; Terasaki M; Tomoyasu M; Nohtomi K; Kim-Kaneyama J; Miyazaki A; Hirano T
    Diabetologia; 2011 Oct; 54(10):2649-59. PubMed ID: 21786155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of the bone tissue material properties in type 1 diabetes mellitus: A Fourier transform infrared microspectroscopy study.
    Mieczkowska A; Mansur SA; Irwin N; Flatt PR; Chappard D; Mabilleau G
    Bone; 2015 Jul; 76():31-9. PubMed ID: 25813583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model.
    Mieczkowska A; Millar P; Chappard D; Gault VA; Mabilleau G
    Calcif Tissue Int; 2020 Sep; 107(3):281-293. PubMed ID: 32642787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.
    Merani S; Truong W; Emamaullee JA; Toso C; Knudsen LB; Shapiro AM
    Endocrinology; 2008 Sep; 149(9):4322-8. PubMed ID: 18511515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis.
    Srivastava S; Shree P; Pandey H; Tripathi YB
    Biomed Pharmacother; 2018 Jan; 97():330-338. PubMed ID: 29091882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats.
    Freyse EJ; Berg S; Kohnert KD; Heinke P; Salzsieder E
    Biol Chem; 2011 Mar; 392(3):209-15. PubMed ID: 21281062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.